Two neoadjuvant immunotherapy combinations for head and neck cancer substantially increased the response rate versus a single ...

Among trial finishers, omalizumab and oral immunotherapy offered similar protection against food allergies, and some people ...

Chronic cutaneous adverse events affected 8% of patients after checkpoint inhibitor therapy in a cohort study, often ...

After surviving a stage four diagnosis, Jenn Henry is sharing her story to encourage others not to ignore the warning signs.

| Is immunotherapy the future of cancer treatment? In the latest episode of Podnosis, Dr. Steven O’Day of Agenus discusses ...

Adding immunotherapy to new KRAS inhibitors boosted responses in preclinical models, setting the stage for future trials of the combination strategy.

A discovery by Mayo Clinic researchers may help explain why immunotherapy hasn't been helpful for many patients with ...

Agenus Chief Medical Officer Dr. Steven O'Day joined Fierce's Chris Hayden on a recent sponsored episode of The Top Line ...

In this interview, News Medical speaks with Olivier Negre, Chief Scientific Officer at Smart Immune, about how immunotherapy is being revolutionized.

Treatment with the T-cell immunotherapy Orca-T improved survival free of moderate-to-severe chronic graft-versus-host disease ...

Researchers from Moffitt Cancer Center have found a new way to boost cancer immunotherapy by targeting a protein called ...

GeekWire Award finalists for Health Innovation of the Year are dominated by ventures that aim to outwit cancer with ...